LYPD2 | LY6/PLAUR domain containing 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MARCH4 | Membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase | Predicted membrane proteins
| | | | | Tissue enhanced |
MBOAT4 | Membrane bound O-acyltransferase domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
MFSD4 | Major facilitator superfamily domain containing 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MMEL1 | Membrane metallo-endopeptidase-like 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYEOV | Myeloma overexpressed | Predicted membrane proteins
| | | | | Tissue enhanced |
MYRF | Myelin regulatory factor | Enzymes Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
NKX2-2 | NK2 homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NMUR2 | Neuromedin U receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
OVOL2 | Ovo-like zinc finger 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PIGY | Phosphatidylinositol glycan anchor biosynthesis, class Y | Predicted membrane proteins
| | | | | Tissue enhanced |
PIK3C2G | Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PLA2G10 | Phospholipase A2, group X | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PTGDR2 | Prostaglandin D2 receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
RAB27B | RAB27B, member RAS oncogene family | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
RASEF | RAS and EF-hand domain containing | Predicted intracellular proteins
| | | | | Tissue enhanced |
RASSF6 | Ras association (RalGDS/AF-6) domain family member 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
REP15 | RAB15 effector protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
RFX6 | Regulatory factor X, 6 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
RNF223 | Ring finger protein 223 | Predicted membrane proteins
| | | | | Tissue enhanced |
S100P | S100 calcium binding protein P | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SHH | Sonic hedgehog | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC26A9 | Solute carrier family 26 (anion exchanger), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC35D3 | Solute carrier family 35, member D3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC9A2 | Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLX1A-SULT1A3 | SLX1A-SULT1A3 readthrough (NMD candidate) | Predicted intracellular proteins
| | | | | Tissue enhanced |
SMIM6 | Small integral membrane protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
SOSTDC1 | Sclerostin domain containing 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
SOX21 | SRY (sex determining region Y)-box 21 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SRMS | Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SSTR1 | Somatostatin receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SULT1C2 | Sulfotransferase family, cytosolic, 1C, member 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SYTL5 | Synaptotagmin-like 5 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM211 | Transmembrane protein 211 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM238 | Transmembrane protein 238 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMPRSS3 | Transmembrane protease, serine 3 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TRIM50 | Tripartite motif containing 50 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TRIM73 | Tripartite motif containing 73 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TRIM74 | Tripartite motif containing 74 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TRNP1 | TMF1-regulated nuclear protein 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
UNC5CL | Unc-5 homolog C (C. elegans)-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
UPK1B | Uroplakin 1B | Predicted membrane proteins
| | | | | Tissue enhanced |
VILL | Villin-like | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
VSIG2 | V-set and immunoglobulin domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |